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Abstract (unstructured; 150 words) 
Trichotillomania (Hair Pulling Disorder) and Skin Picking Disorder are common 
neuropsychiatric disorders, but are under-recognized professionals. Affected individuals 
repeatedly pull out their own hair or pick at their skin, and these symptoms not only 
impact negatively on the individual due to the time they occupy, but can also lead to 
considerable physical disfigurement, with concomitant loss of self-esteem, and avoidance 
of social activities and intimate relationships. The behaviors may also have potentially 
serious physical consequences. Trichotillomania and skin picking frequently co-occur, 
and both disorders commonly present with co-occurring depression or anxiety. 
Behavioral therapy appears, at this time, to be the most effective treatment for both 
disorders. Pharmacotherapy, in the form of N-acetyl cysteine or olanzapine, may play a 
role in treatment as well. 
 
Clinical Context 
Trichotillomania 
Trichotillomania, also known as Hair Pulling Disorder, is characterized by the 
repetitive pulling out of one’s own hair leading to hair loss and functional impairment1 
(see Table 1 for diagnostic criteria). The most common sites pulled include the scalp, 
eyebrows, and eyelashes; although any bodily site with hair can be affected.
2-3
 Pulling 
from multiple sites is common and pulling episodes can last from a few minutes to 
several hours.
4
  Nationwide epidemiological studies of Trichotillomania are lacking; but 
small studies examining the prevalence of Trichotillomania among college students in the 
United States, adolescents in Israel, and older adults within the community have found 
current rates ranging from 0.5% to 2.0%.
5-7
 
Onset of hair pulling is generally in late childhood or early adolescence although 
onset of pulling behaviors can occur at any age.
4,8
 Trichotillomania appears to have a 
similar clinical presentation across cultures.
6,9
 In adults, Trichotillomania has a large 
female preponderance, however in childhood, sex distribution has been found to be 
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equal.
10-11
 Trichotillomania is frequently associated with reduced self-esteem, and 
avoidance of social situations due to shame and embarrassment from the pulling and its 
consequences.
3,12
 Even though Trichotillomania interferes with a person’s quality of life, 
the majority (about 65%) of individuals never seek treatment.
3
 
The clinical presentation of trichotillomania varies.  Individuals may report one or 
many triggers for their pulling, and these include sensory triggers such as the feeling of 
the hair or the scalp, emotional triggers such as feeling anxious, bored, or angry, and 
cognitive triggers such as thoughts about hair and appearance or rigid thinking.
4
 Many 
patients report not being fully aware of their pulling behaviors, also referred to as 
“automatic” pulling, whereas “focused” pulling generally occurs when the patient sees or 
feels a hair that is “not right”, that the hair may feel coarse, kinky, or “out of place”.4 
Most patients pull with varying degrees of focused and automatic pulling, which can 
fluctuate over time. 
 
Skin Picking Disorder 
Skin Picking Disorder, also referred to as Pathological Skin Picking, Neurotic 
Excoriation, Dermatillomania, or Psychogenic Excoriation, is characterized by the 
repetitive and compulsive picking of skin, leading to tissue damage
1
 (see Table 2 for 
diagnostic criteria). Although most individuals at some time pick at their skin, either to 
smooth out irregularities or to improve blemishes or acne, clinicians must differentiate 
between normal picking and more pathological forms. The diagnostic criteria for Skin 
Picking Disorder require that picking be recurrent and result in skin lesions, thereby 
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reflecting the frequency and intensity of the picking.
1
 In addition, the clinical diagnosis 
requires that the picking result in the person feeling distressed or impaired. 
Community prevalence studies in the United States have found that Skin Picking 
Disorder is relatively common. In a study of 354 adult subjects, 19 (5.4%) reported 
significant picking with associated distress/impact.
13 
A second study, comprised of 2513 
telephone interviews in a representative sample, found that 1.4% picked to the point of 
having noticeable skin damage and reported distress or impairment due to the picking.
14
 
Research suggests that the age of onset for Skin Picking Disorder varies substantially and 
may occur during childhood, adolescence, or adulthood.
15-16
 The clinical characteristics 
of Skin Picking Disorder appear the same across age cohorts and cultures.
16
 Many 
individuals with Excoriation Disorder report that the behavior began with the onset of a 
dermatological condition such as acne, but the picking continues even after the 
dermatological condition clears.   
The phenomenology of Skin Picking Disorder bears striking similarities to that of 
Trichotillomania. Individuals with Skin Picking Disorder spend a significant amount of 
time each day picking their skin, with many reporting that the picking behavior occupies 
several hours each day.
17
 Although the face is the most commonly reported site of 
picking, other areas, such as the hands, fingers, arms, and legs, are also common targets. 
Picking from more than one body area is normal with one study finding that people 
picked at an average of 4.5 sites.
17
 The time spent picking, as well as the consequences of 
picking such as scarring, results in dysfunction related to work and social activities.
18
 
Triggers to pick vary greatly between individuals, and multiple triggers are the norm.  
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Stress, anxiety, time away from scheduled activities, boredom, and feeling tired or angry, 
have all been reported as triggers.
16
 
 
Common Characteristics 
Symptoms 
Both Trichotillomania and Skin Picking Disorder may result in unwanted medical 
consequences. Pulling of hair can lead to skin damage if sharp instruments, such as 
tweezers or scissors, are used to pull the hairs. Over 20% of patients eat hair after pulling 
it out (“trichophagia”), which can result in gastrointestinal obstruction and the formation 
of intestinal hair-balls (“trichobezoars”) requiring surgical intervention.19 In the case of 
skin picking, the behavior may result in significant tissue damage and often leads to 
medical complications such as localized infections and even septicemia (38% report 
needing some medical intervention due to picking).
20
 The repetitive, excoriative nature of 
picking in severe cases may even warrant skin grafting or blood transfusions.
16,20
   
Patients often perceive Trichotillomania or Skin Picking Disorder as nothing more 
than “bad habits” rather than recognized psychiatric conditions, and the majority have 
never sought treatment or discussed their behaviors with health care professionals. In 
fact, fewer than 20% of patients with skin picking and approximately 40% with 
Trichotillomania seek treatment.
3, 18
   
  
 Neurobiology 
Much remains unknown about the neurobiological underpinnings of these two 
disorders. Early research suggests that Trichotillomania is familial with heritability 
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estimates ranging from 0.32 to 0.78.
21-22
  In the case of skin picking, one study that 
examined 2,518 twins from the Twins UK adult twin registry found that clinically 
significant skin picking was endorsed by 1.2% of twins and that additive and non-
additive genetics factors accounted for slightly more than over 40% of the variance in 
skin picking, with the remaining variance attributable to non-shared environmental 
factors.
23 
Several brain structures and functions have been implicated in both 
Trichotillomania and Skin Picking Disorder. Excess gray matter density has been found 
in patients with Trichotillomania compared to controls, in the striatum, amygdalo-
hippocampal formation, frontal and cingulate cortices, and supplementary motor cortex.
24
 
In a recent functional neuroimaging study, patients with Trichotillomania exhibited 
dampening of nucleus accumbens responses to reward anticipation (but relative 
hypersensitivity to gain and loss outcomes) as compared to controls.
25
 Other 
neuroimaging studies have found disorganization of white-matter tracts involved in motor 
generation and suppression (i.e. bilateral anterior cingulate and right orbitofrontal and 
inferior frontal cortices) in both disorders.
26-27
 Neuropsychological studies have also 
shown that patients with Trichotillomania and Skin Picking Disorder exhibit deficits in 
cognitive abilities that are linked to the functioning of the frontal lobe and its related 
fronto-subcortical structures, such as executive functioning deficits, motor impulsivity, 
and insufficient cognitive-behavioral flexibility.
28-29 
 
Psychological theories of etiology 
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Because negative emotions such as anxiety, tension, and sadness often precede 
pulling and picking episodes, the question arises as to the role of these behaviors in 
regulating emotional states or stressful events.
7,30
 Therefore picking and pulling may 
function as a means for the person to escape from or avoid aversive experiences and the 
temporary reduction in these negative emotions maintains the behavior through a 
negative reinforcement cycle.
31
  Studies that have  measured emotional regulation in 
individuals with and without pulling and picking found that individuals have greater 
difficulty regulating negative affective states than controls.
32-33
 In a related fashion, 
boredom may also trigger picking and pulling in some individuals.
11,30
 This has led some 
to hypothesize that pulling and picking may similarly help to adjust negative emotions 
brought on by a feeling of perfectionism characterized by unwillingness to relax.
34
 This 
theory suggests that the perfectionism leads to feelings of frustration, impatience, and 
dissatisfaction when standards are not met and to boredom when productivity is 
impossible. Picking and pulling may therefore function as a means of releasing tension 
generated by these emotions. Pulling and picking are perhaps positively reinforced by a 
feeling of ‘taking action’.31 
 
Treatment Strategies and Evidence 
Diagnosis 
Treatment strategies are based on an accurate diagnosis. Misdiagnosis of 
Trichotillomania and Skin Picking Disorder is unfortunately common (Table 3). 
Individuals may be misdiagnosed with OCD, an anxiety disorder, body dysmorphic 
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disorder, or even drug addiction. Because treatments differ between these disorders and 
Trichotillomania and Skin Picking Disorder, proper diagnosis is necessary. 
 
Psychotherapy 
The evidence base for psychotherapy for Trichotillomania and Skin Picking 
Disorder is small but suggest the use of behavioral therapy for both disorders.  Behavioral 
therapy for trichotillomania has generally used habit reversal therapy (HRT) and may 
have included components of acceptance and commitment therapy and dialectical 
behavior therapy as well.  There are seven controlled studies of behavioral therapy, using 
HRT alone or with other components, in Trichotillomania and two controlled 
psychosocial treatment studies for Skin Picking Disorder.  The studies for skin picking 
disorder involve one using of HRT and the other using cognitive-behavioral therapy.  
There are no controlled studies of other traditional therapies. 
 
Habit Reversal Therapy (HRT) 
Habit reversal training (HRT) was first developed approximately 40 years ago by 
Azrin and Nunn for the treatment of nervous habits and tics.
35
 Although used in multiple 
forms throughout the years, the core aspects of HRT include self-monitoring (i.e., asking 
the patient to track his/her hair pulling, picking, etc.), awareness training, competing 
response training, and stimulus control procedures (i.e., modifying the environment to 
reduce cues for hair pulling or skin picking).  Self-monitoring may begin by using a self-
monitoring form that the patient fills out on a daily basis and maintains throughout the 
therapy period. Awareness training consists of having the therapist ask the patient to 
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describe in detail and even reenact the picking or pulling.  The patient also needs to 
identify triggers for the pulling and picking.  In competing response training, patients are 
taught at the earliest sign of pulling, or of the urge to pull, to engage in a behavior that is 
physically incompatible with pulling for a brief period of time until the urge subsides. For 
example, someone who pulls her hair might clench her fists or place her hands 
underneath her legs upon identifying a warning sign for hair pulling.  Competing 
responses must be opposite to that of the targeted behavior, they must be maintained for 1 
minute or until the urge to pull or pick subsides, and they should be socially 
inconspicuous. Stimulus control consists of modifying the environment to reduce the 
triggers of pulling or picking. For example, if someone pulls at work only when their 
office door is closed, then they need to keep the door open during the work day.  HRT is 
similar to many other types of behavioral therapy.  HRT differs somewhat from standard 
cognitive behavioral therapy in that the focus of HRT is on behavioral change and not 
generally on cognitive strategies to address dysfunctional thoughts that precipitate 
pulling. 
HRT appears to be superior to wait list and minimal attention control based on 
controlled studies.
36
 In addition, HRT has shown benefit with the addition of components 
of acceptance and commitment therapy and dialectical behavior therapy.
37-38
  HRT can be 
delivered in person, online using a self-help method, or in a group format.
36, 39-40 
Acute 
treatment gains obtained from HRT have been generally maintained from three to six 
months.  
Typically HRT is conducted on a weekly basis, although higher severity of the 
disorder may necessitate more frequent sessions. HRT has shown benefit in many 
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different frequency formats and anywhere from 4-22 sessions (usually 60 minute 
sessions) may be helpful. Although in practice many clinicians use a combination of HRT 
and more traditional cognitive therapy, the empirical data support HRT as the first-line 
psychotherapy treatment for these disorders.
 
 
Pharmacotherapy 
 There are currently no pharmacotherapies that would be universally accepted as 
first-line treatments for Trichotillomania or Skin Picking Disorder. There are eight 
double-blind studies published for the treatment of Trichotillomania and four double-
blind, placebo-controlled clinical trials for Skin Picking Disorder.  Generally, 
pharmacotherapy should be avoided in children. A recent Cochrane review concluded 
that although clomipramine has demonstrated some benefit for Trichotillomania, there is 
no strong evidence of a treatment effect for the selective serotonin reuptake inhibitors 
(SSRIs).
41 
Glutamatergic agents have shown some promise in Trichotillomania , may have a 
useful role in the treatment of skin-picking disorder as well. One key example is n-
acetylcysteine (NAC), which has demonstrated benefit in a double-blind placebo-
controlled study for Trichotillomania and in case reports for Skin Picking Disorder.
42-43
 
Based on the Trichotillomania data, NAC may be useful for reducing the urge to pick. 
Previous research has used up to 1200mg twice a day as a target dose with expected 
clinical benefits being observed after approximately 9 weeks. Side effects are generally 
mild and usually only involve some bloated feelings and flatulence. 
 11 
Based on data from their potential efficacy in OCD, antipsychotic medications 
have also been sued in the treatment of Trichotillomania. One small (n=23) double-blind, 
placebo-controlled study of olanazapine found the medication significantly beneficial in 
reducing the symptoms of Trichotillomania after 12 weeks using a mean dose of 10.8mg 
per day.
44
 Olanzapine has been associated with metabolic syndrome and so the decision 
to use it in the treatment of Trichotillomania and Skin Picking Disorder needs to be 
tempered by its adverse side effect profile. 
Opioid antagonists (e.g., naltrexone), which reduce self-licking in dogs with acral 
lick dermatitis, may also represent a viable option for Trichotillomania and Skin Picking 
Disorder, although such benefit has been limited to small samples (case reports of single 
patients, often with Prader-Willi) of individuals with Excoriation Disorder. Based on an 
8-week double-blind placebo-controlled study of naltrexone (dosing of 50mg/day up to 
150mg/day) in the treatment of 52 subjects with Trichotillomania, however, naltrexone 
may be useful for those with hair pulling or skin picking who have a family history 
positive for alcohol use disorders.
45
  
 
Sequencing Treatment 
Psychotherapeutic and pharmacological treatments have documented evidence as 
effective monotherapies as well as in a combined treatment strategy.
46
 Although, the 
optimal sequence of treatments has not yet been identified, we recommend HRT 
monotherapy for individuals who are motivated to cooperate with therapy demands, do 
not have severe depressive symptoms, or prefer not to take medications.  Medication 
treatment as monotherapy (e.g., NAC, olanzapine, clomipramine) is recommended for 
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individuals who are not able to engage in HRT, report a previous response to a 
medication, or prefer medication treatments over psychotherapy.  
 
Treatment of Comorbidities 
 Co-occurring anxiety and depression are common among individuals with 
trichotillomania and skin picking disorder.  Assessment should attempt to understand, if 
possible, the temporal relationship of these comorbidities with trichotillomania and skin 
picking disorder – for example, is the depression or anxiety secondary to the effects of 
the hair pulling or skin picking? If so, then focusing on the hair pulling or skin picking 
would be the recommended initial approach.  If such a temporal relationship is unclear, 
however, then expanding the behavioral therapy to also include cognitive approaches 
would be beneficial for both disorders potentially. In terms of pharmacotherapy, many 
individuals may need an antidepressant for the comorbid diagnoses even when the data 
suggest that they are largely ineffective for trichotillomania and skin picking disorder. 
 
Prognosis 
If Trichotillomania and Skin Picking Disorder are left untreated, the course is 
usually chronic, often with waxing and waning symptoms. Without treatment, response 
rates in adults are low (approximately 14%).
3
  When diagnosed early and appropriately 
treated, however, up to 50% of individuals may experience symptom reduction at least 
for the short term.
47
 Therefore, accurate and early diagnosis followed by evidence-based 
treatment approaches are needed to prevent associated disability. 
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Questions and Controversy 
 Clinical treatment trials for Trichotillomania and Skin Picking Disorder have been 
largely short-term and have predominantly involved young or middle-aged adults. Data 
are lacking on the long-term benefit and risks among both children and the elderly. More 
research is also needed to identify predictors of poor outcomes. 
 Although HRT has demonstrated some benefit for Trichotillomania and Skin 
Picking Disorder, there are no data regarding how well HRT is performed in the 
community and what the results of HRT are when not performed by expert clinicians.  
 HRT has shown some promise but there are few if any data on whether more 
traditional therapies such as cognitive therapy or supportive therapy might also be 
beneficial for trichotillomania and skin picking disorder. 
 The genetic features of Trichotillomania and Skin Picking Disorder remain 
incompletely understood. Genes that confer susceptibility to these disorders have not yet 
been identified. Studies are needed to identify childhood and adolescent risk factors for 
Trichotillomania and Skin Picking Disorder and on how these variables interact with 
genetic factors. This may allow for the identification of children at risk and the 
development of early-intervention strategies.  
The clinical trial data have largely focused on the core symptoms of 
Trichotillomania and Skin Picking Disorder but effective treatments are also needed for 
associated cognitive impairment and social dysfunction.  
Although a range of etiological theories have been proposed, there is still a 
paucity of data examining this important area.  
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Improved dissemination of information about psychotherapy and medication 
shown to be effective for these disorders is warranted, since their availability remains 
limited. 
 
Recommendations 
 If untreated, Trichotillomania and Skin Picking Disorder are often chronic 
illnesses and may result in substantial psychosocial dysfunction and even lead to 
life-threatening medical problems.  
 The evaluation for Trichotillomania and Skin Picking Disorder must begin with a 
thorough psychiatric assessment to establish an accurate diagnosis, assess for co-
occurring psychiatric disorders, and rule out other disorders in the differential. 
 In the case of Skin Picking Disorder, a thorough evaluation from a dermatologist 
with knowledge about the disorder may be necessary to assess for underlying 
dermatological conditions that may cause or worsen skin picking. 
 Habit reversal therapy has demonstrated benefit for both Trichotillomania and 
Skin Picking Disorder but finding someone trained in habit reversal therapy is 
essential for appropriate treatment outcomes. 
 In terms of pharmacotherapy, there is little evidence that SSRIs are beneficial. 
Based on our clinical experience, however, we find that N-acetyl cysteine in doses 
of 1200mg twice a day has been quite helpful in reducing urges to pick and pull 
and probably should be considered as the initial pharmacotherapy treatment. 
 Since treatment response is often only partial, attending to quality of life and 
long-term functioning is critical.  
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Multiple Choice Questions 
 
1. Which of these pharmacological options would be your treatment of choice for 
moderate-severe Trichotillomania in an adult patient? (select one) 
 
a. Fluoxetine  
b. Atomoxetine 
c. N-Acetyl cysteine  
d. Clonazepam  
e. Escitalopram 
 
2. Which statement in true in relation to Trichotillomania? (select one) 
 
a. It has an equal gender ratio in adults 
b. “Baby trich” requires early multimodal intervention including pharmacotherapy 
c. Hair can be pulled from any body site with hair 
d. Peak age of onset is around 25 years of age 
e. The same treatments as for OCD are indicated 
  
 
3. Which statement best captures our understanding of Trichotillomania and Skin 
Picking Disorder? (select one) 
 
a. Cognitive profile identical to that of schizophrenia 
b. Dysfunction of basal ganglia (striatum), anterior cingulate cortex, and frontal 
lobes, has been implicated  
c. Symptoms usually occur secondary to focal brain lesions that can be viewed 
on single-subject MRI scan 
d. Genetic factors play no role in risk of developing these two disorders 
e. Robust attentional processing bias towards negative stimuli (sad faces, sad 
words) 
 
4. In terms of the possible consequences of Skin Picking Disorder, which of these is 
not associated with the condition? (select one) 
 
a. Localized skin infections 
b. Systemic sepsis 
c. Gastrointestinal obstruction 
d. Scarring 
e. Permanent disfigurement 
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Table 1. Criteria for Trichotillomania: 
• Pulling of hair which results in hair loss 
• The person endorses trying to either decrease or stop pulling 
• Significant distress or impairment in some aspect of social, work, or other area of 
functioning results from pulling 
• The pulling cannot be attributed to another medical condition 
• The pulling cannot be better explained by another mental health condition (for 
example, pulling to improve one’s appearance or a perceived defect as seen in body 
dysmorphic disorder) 
This table is adapted from the American Psychiatric Association.
1
 
 
Table 2. Criteria for Skin picking Disorder 
• Picking of skin that results in lesions 
• The person endorses trying to either decrease or stop picking 
• Significant distress or impairment in some aspect of social, work, or other area of 
functioning results from picking 
• The picking cannot be attributed to the physical effects of drug use (such as 
cocaine) or a medical condition 
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• The pulling cannot be better explained by another mental health condition (for 
example, picking to improve one’s appearance or a perceived defect as seen in body 
dysmorphic disorder, delusions or hallucinations as seen in a psychotic disorder, 
stereotypies, or international self-harm in a non-suicidal self-injury) 
This table is adapted from the American Psychiatric Association.
1
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Table 3. Some Common Misdiagnoses in Patients with Trichotillomania and Skin 
Picking Disorder 
Misdiagnosis Reasons for and prevention of misdiagnosis 
Obsessive Compulsive Disorder (OCD) Trichotillomania and skin picking are often 
misdiagnosed as OCD because they involve 
compulsive behaviors. Trichotillomania and skin 
picking however generally lack significant 
obsessional thoughts and do not appear to respond to 
traditional OCD treatments.  
Anxiety Disorder Many clinicians assume that Trichotillomania and 
skin picking are merely manifestations of anxiety – 
i.e. nervous habits. Although anxiety may worsen 
pulling and picking, the behaviors persist even when 
no anxiety is present.  
Stimulant Addiction It is not uncommon for individuals who use 
stimulants, either illicit ones or by prescription, to 
report skin picking or possibly worsening of hair 
pulling.   
Body Dysmorphic Disorder (BDD) BDD is characterized by obsessions about and 
preoccupation with a perceived defect of one’s 
physical appearance. In BDD, individuals may pull 
hair with the aim of correcting a perceived defect of 
their appearance (e.g., “I know that my arms are too 
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hairy and disgusting to people”) or pick their skin to 
improve their appearance. 
Self-Injurious Behavior Hair pulling and skin picking are not the same thing 
as self-injury. Pulling and picking are often used as a 
means of correcting a problem with the hair or skin 
and are not generated from the complex 
psychological factors that give rise to self-injury such 
as cutting behavior.  
  
 
